Immune activation by combination human lymphokine-activated killer and dendritic cell therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc2011290.pdf
Reference34 articles.
1. Adam C, King S, Allgeier T, Braumuller H, Luking C, Mysliwietz J, Kriegeskorte A, Busch DH, Rocken M, Mocikat R (2005) DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 106 (1): 338–344
2. Balsamo M, Zambello R, Teramo A, Pedrazzi M, Sparatore B, Scordamaglia F, Pende D, Mingari MC, Moretta L, Moretta A, Semenzato G, Vitale M (2009) Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30. Exp Hematol 37 (10): 1167–1175
3. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392 (6673): 245–252
4. Berdeja JG, Hess A, Lucas DM, O’Donnell P, Ambinder RF, Diehl LF, Carter-Brookins D, Newton S, Flinn IW (2007) Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab. Clin Cancer Res 13 (8): 2392–2399
5. Borg C, Jalil A, Laderach D, Maruyama K, Wakasugi H, Charrier S, Ryffel B, Cambi A, Figdor C, Vainchenker W, Galy A, Caignard A, Zitvogel L (2004) NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104 (10): 3267–3275
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapy of Clear-Cell Renal-Cell Carcinoma;Cancers;2024-05-31
2. Natural Compounds for Inhibiting Oncogenic Microbiota: A Review of Their Therapeutic Applications;Pathogens Associated with the Development of Cancer in Humans;2024
3. Promising Highly Targeted Therapies for Cholangiocarcinoma: A Review and Future Perspectives;Cancers;2023-07-20
4. Advances in NK cell therapy for hematologic malignancies: NK source, persistence and tumor targeting.;Blood Reviews;2023-07
5. Current progress and challenges of immunotherapy in gastric cancer: A focus on CAR-T cells therapeutic approach;Life Sciences;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3